Posted by Joel Rothman
January 18th, 2009
In the conclusion to the FTC’s follow-up action against Kevin Trudeau for making deceptive claims about his books, a federal judge has ordered Trudeau to pay more than $37 million for violating a 2004 stipulated order by misrepresenting the content of his book, “The Weight Loss Cure ‘They’ Don’t Want You to Know About.” We [...]
Posted by Joel Rothman
January 18th, 2009
Back in September we reported on FTC action against companies allegedly selling bogus cancer cures. To read our original post, click here. The FTC press release page on this matter lists the actions and contains links to the case files for each. Among the cases is one entitled In the Matter of Daniel Chapter One, [...]
Posted by Vincent Annunziata
January 16th, 2009
A federal district court has ordered the marketers of three dietary supplements (Thermalean, Lipodrene, and Spontane-ES) to pay more than $15 million for deceiving consumers about the products’ safety and effectiveness. The court imposed the final monetary judgment and permanent prohibitions against the marketers in December 2008, after granting the Federal Trade Commission’s motion for [...]
Posted by Vincent Annunziata
December 8th, 2008
A Utah-based operation that lured online customers with free samples of a purported weight-loss supplement in a scheme to obtain their credit or debit card information has agreed to pay $150,000 to settle Federal Trade Commission charges of deceptive and unfair marketing, and of violations of federal regulations governing the electronic transfer of funds. According [...]
Posted by Vincent Annunziata
December 8th, 2008
The Federal Trade Commission announced it has approved publication of a Federal Register notice seeking public comments on proposed revisions to the Guides Concerning the Use of Endorsements and Testimonials in Advertising. In a Federal Register notice published in January 2007, the FTC sought public comment on the overall costs, benefits, and regulatory and economic [...]
Posted by Joel Rothman
September 21st, 2008
The FTC announced 11 law enforcement actions challenging deceptive advertising of bogus cancer cures. The FTC charged the companies with making unsupported claims that their products cured or treated one or more types of cancer. In each case, the company is charged with violating the FTC Act, which bars deceptive claims. Some complaints allege that [...]